Treatment of chronic hepatitis D
- 1 November 2007
- journal article
- review article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 14 (s1), 58-63
- https://doi.org/10.1111/j.1365-2893.2007.00917.x
Abstract
Despite recent advances in the treatment of chronic viral hepatitis, therapy of chronic hepatitis D is not yet satisfactory. The only option currently available is interferon-alpha (IFN), whose efficacy is related to the dose and duration of treatment. However, the rate of sustained hepatitis D virus (HDV) clearance after a 1-year course with high doses of standard IFN is low. Better results have recently been reported with pegylated IFN both in IFN-naïve and in previous nonresponders to standard IFN, suggesting the use of pegylated IFN as a first-line therapy in chronic hepatitis D. Nucleoside analogues that inhibit hepatitis B virus (HBV) are ineffective against HDV and combination therapy with lamivudine or ribavirin has not shown significant advantages over monotherapy with either standard or pegylated IFN. Because the ultimate goal of treatment is eradication of both HDV and HBV, in responders IFN therapy should be continued as long as possible until the loss of hepatitis B surface antigen, adjusting the dose to patient tolerance. However, because side-effects are common, continuous monitoring is mandatory. Although the first results obtained with pegylated IFN have been encouraging, the rate of sustained virological response is still low and the rate of relapse high, emphasizing the need for developing novel classes of antivirals specifically interfering with the life cycle of this unique viruKeywords
This publication has 38 references indexed in Scilit:
- Peginterferon and Ribavirin for Chronic Hepatitis CNew England Journal of Medicine, 2006
- Treatment of chronic hepatitis delta with pegylated interferon‐α2bLiver International, 2006
- Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trialJournal of Gastroenterology and Hepatology, 2006
- Clevudine Inhibits Hepatitis Delta Virus Viremia: a Pilot Study of Chronically Infected WoodchucksAntimicrobial Agents and Chemotherapy, 2005
- Susceptibility of Human Hepatitis Delta Virus RNAs to Small Interfering RNA ActionJournal of Virology, 2003
- Delta hepatitis: an updateJournal of Hepatology, 2003
- Famciclovir treatment of chronic delta hepatitisJournal of Hepatology, 2002
- The French experience of treatment of chronic type D hepatitis with a 12‐month course of interferon alpha‐2B. Results of a randomized controlled trialLiver International, 1995
- Treatment of chronic hepatitis D virus infection with low and high doses of interferon-α2a: Utility of polymerase chain reaction in monitoring antiviral responseHepatology, 1994
- A randomized controlled trial of a 12-month course of recombinant human interferon-α in chronic delta (type D) hepatitis: A multicenter Italian studyHepatology, 1991